Dr. Reddy's Labs Files 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 13, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
DRL filed a 6-K on Nov 13, 2025. Standard reporting.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 13, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer.
Why It Matters
This filing indicates ongoing reporting requirements for Dr. Reddy's Laboratories as a foreign private issuer, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate elevated risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000683 (filing_id) — Accession Number
- 20251113 (date) — Filing Date
- Hyderabad, India (location) — Principal Executive Office
FAQ
What type of company is Dr. Reddy's Laboratories Ltd. according to the filing?
Dr. Reddy's Laboratories Ltd. is identified as a pharmaceutical preparations manufacturer (SIC code 2834).
What is the filing date of this Form 6-K?
The filing date is November 13, 2025.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-11-13 08:06:45
Filing Documents
- rdy0819_6k.htm (6-K) — 52KB
- rdy0819_ex99-1.htm (EX-99.1) — 68KB
- rdy0819_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0819_ex99-1img02.jpg (GRAPHIC) — 8KB
- rdy0819_ex99-1img03.jpg (GRAPHIC) — 7KB
- 0001575872-25-000683.txt ( ) — 156KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: November 13, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3